Diabetes drug leads to notable weight loss in people with obesity – study

Experts say the apparent effects of a weekly dose of tirzepatide are potentially game changing

A weekly dose of a diabetes drug appears to lead to significant weight loss in people with obesity, in a development experts have hailed as gamechanging.

Obesity causes 1.2 million deaths in Europe each year, according to the World Health Organization, and the UK has one of the worst obesity rates.